UK M&A activity down in January amid uncertain US opportunities
Deal numbers dropped in January this year compared to last, with outbound deals trumping inbound transactions.
Investment
BIA report: UK biotech investment surged to £3.5bn in 2024
Activist investor Starboard cries foul play in exec U-turn at Pfizer
Activist investor Starboard forges $1bn stake in Pfizer to swing profits
Investors anticipate “bounce-back” in European private investment
Investors grapple with more choices in big year for pharma fundraising
Difficult biotech investment ecosystem forces focus on value
Signal: Dutch health investor Gilde raises $804m for health startup fund
